vs
Apyx Medical Corp（APYX）与泰利福（TFX）财务数据对比。点击上方公司名可切换其他公司
泰利福净利率更高（177.8% vs -6.8%，领先184.5%）。Apyx Medical Corp同比增速更快（34.7% vs -150.5%）。Apyx Medical Corp自由现金流更多（$-2.8M vs $-92.9M）。过去两年泰利福的营收复合增速更高（NaN% vs NaN%）
Apyx Medical前身是博维医疗，是美国的医疗器械制造商，专注生产电外科产品与能源技术相关医疗设备，公司总部位于佛罗里达州克利尔沃特，在保加利亚设有生产工厂。
泰利福（Teleflex）总部位于美国宾夕法尼亚州韦恩，是专业医疗设备供应商，产品广泛应用于重症监护、外科手术等各类诊疗场景。公司年营收达24亿美元，在全球40个国家开展业务，员工总数超15000人。经过数年的收并购与业务剥离，公司于2011年完成业务调整，全面聚焦医疗设备制造领域。
APYX vs TFX — 直观对比
营收规模更大
APYX
是对方的-0.0倍
$-401.9M
营收增速更快
APYX
高出185.3%
-150.5%
净利率更高
TFX
高出184.5%
-6.8%
自由现金流更多
APYX
多$90.1M
$-92.9M
两年增速更快
TFX
近两年复合增速
36.8%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $19.2M | $-401.9M |
| 净利润 | $-1.3M | $-714.3M |
| 毛利率 | 62.6% | — |
| 营业利润率 | 0.1% | — |
| 净利率 | -6.8% | 177.8% |
| 营收同比 | 34.7% | -150.5% |
| 净利润同比 | 71.9% | -422.7% |
| 每股收益（稀释后） | — | $-15.85 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APYXTFX
| Q4 25 | $19.2M | $-401.9M | ||
| Q3 25 | $12.9M | $913.0M | ||
| Q2 25 | $11.4M | $780.9M | ||
| Q1 25 | $9.4M | $700.7M | ||
| Q4 24 | $14.2M | $795.4M | ||
| Q3 24 | $11.5M | $764.4M | ||
| Q2 24 | $12.1M | $749.7M | ||
| Q1 24 | $10.2M | $737.8M |
净利润APYXTFX
| Q4 25 | $-1.3M | $-714.3M | ||
| Q3 25 | $-2.0M | $-408.9M | ||
| Q2 25 | $-3.8M | $122.6M | ||
| Q1 25 | $-4.2M | $95.0M | ||
| Q4 24 | $-4.6M | $-136.7M | ||
| Q3 24 | $-4.7M | $111.0M | ||
| Q2 24 | $-6.6M | $80.0M | ||
| Q1 24 | $-7.6M | $15.3M |
毛利率APYXTFX
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | 49.5% | ||
| Q2 25 | 62.3% | 55.2% | ||
| Q1 25 | 60.1% | 55.6% | ||
| Q4 24 | 63.0% | 55.3% | ||
| Q3 24 | 60.5% | 56.3% | ||
| Q2 24 | 61.7% | 55.6% | ||
| Q1 24 | 58.1% | 56.4% |
营业利润率APYXTFX
| Q4 25 | 0.1% | — | ||
| Q3 25 | -6.5% | -44.8% | ||
| Q2 25 | -22.6% | 19.9% | ||
| Q1 25 | -32.4% | 17.9% | ||
| Q4 24 | -21.4% | -13.9% | ||
| Q3 24 | -31.6% | 19.5% | ||
| Q2 24 | -45.7% | 15.6% | ||
| Q1 24 | -64.6% | -0.6% |
净利率APYXTFX
| Q4 25 | -6.8% | 177.8% | ||
| Q3 25 | -15.4% | -44.8% | ||
| Q2 25 | -33.2% | 15.7% | ||
| Q1 25 | -44.0% | 13.6% | ||
| Q4 24 | -32.5% | -17.2% | ||
| Q3 24 | -40.9% | 14.5% | ||
| Q2 24 | -54.0% | 10.7% | ||
| Q1 24 | -74.0% | 2.1% |
每股收益（稀释后）APYXTFX
| Q4 25 | — | $-15.85 | ||
| Q3 25 | — | $-9.24 | ||
| Q2 25 | — | $2.77 | ||
| Q1 25 | — | $2.07 | ||
| Q4 24 | — | $-2.89 | ||
| Q3 24 | — | $2.36 | ||
| Q2 24 | $-0.19 | $1.69 | ||
| Q1 24 | $-0.22 | $0.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $31.7M | $378.6M |
| 总债务越低越好 | $37.5M | $2.6B |
| 股东权益账面价值 | $14.5M | $3.1B |
| 总资产 | $66.8M | $6.9B |
| 负债/权益比越低杠杆越低 | 2.58× | 0.85× |
8季度趋势，按日历期对齐
现金及短期投资APYXTFX
| Q4 25 | $31.7M | $378.6M | ||
| Q3 25 | $25.1M | $354.0M | ||
| Q2 25 | $29.3M | $253.7M | ||
| Q1 25 | $31.0M | $284.1M | ||
| Q4 24 | $31.7M | $290.2M | ||
| Q3 24 | $28.0M | $243.2M | ||
| Q2 24 | $32.7M | $238.6M | ||
| Q1 24 | $37.3M | $237.4M |
总债务APYXTFX
| Q4 25 | $37.5M | $2.6B | ||
| Q3 25 | $37.5M | $2.7B | ||
| Q2 25 | $37.5M | $1.9B | ||
| Q1 25 | $37.5M | $1.9B | ||
| Q4 24 | $37.5M | $1.7B | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益APYXTFX
| Q4 25 | $14.5M | $3.1B | ||
| Q3 25 | $5.8M | $3.8B | ||
| Q2 25 | $7.3M | $4.2B | ||
| Q1 25 | $10.5M | $4.1B | ||
| Q4 24 | $14.2M | $4.3B | ||
| Q3 24 | $11.0M | $4.5B | ||
| Q2 24 | $14.7M | $4.6B | ||
| Q1 24 | $20.3M | $4.5B |
总资产APYXTFX
| Q4 25 | $66.8M | $6.9B | ||
| Q3 25 | $57.4M | $7.9B | ||
| Q2 25 | $58.2M | $7.4B | ||
| Q1 25 | $60.2M | $7.2B | ||
| Q4 24 | $64.8M | $7.1B | ||
| Q3 24 | $60.7M | $7.5B | ||
| Q2 24 | $65.4M | $7.4B | ||
| Q1 24 | $70.7M | $7.5B |
负债/权益比APYXTFX
| Q4 25 | 2.58× | 0.85× | ||
| Q3 25 | 6.41× | 0.70× | ||
| Q2 25 | 5.17× | 0.45× | ||
| Q1 25 | 3.57× | 0.47× | ||
| Q4 24 | 2.64× | 0.39× | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.5M | $-92.3M |
| 自由现金流经营现金流 - 资本支出 | $-2.8M | $-92.9M |
| 自由现金流率自由现金流/营收 | -14.6% | 23.1% |
| 资本支出强度资本支出/营收 | 1.4% | -0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-9.1M | $1.4M |
8季度趋势，按日历期对齐
经营现金流APYXTFX
| Q4 25 | $-2.5M | $-92.3M | ||
| Q3 25 | $-3.5M | $107.8M | ||
| Q2 25 | $-1.2M | $7.8M | ||
| Q1 25 | $-702.0K | $73.3M | ||
| Q4 24 | $-2.9M | $202.6M | ||
| Q3 24 | $-4.4M | $231.1M | ||
| Q2 24 | $-4.3M | $91.7M | ||
| Q1 24 | $-6.3M | $112.8M |
自由现金流APYXTFX
| Q4 25 | $-2.8M | $-92.9M | ||
| Q3 25 | $-4.1M | $77.8M | ||
| Q2 25 | $-1.5M | $-26.8M | ||
| Q1 25 | $-757.0K | $43.3M | ||
| Q4 24 | $-3.2M | $170.6M | ||
| Q3 24 | $-4.6M | $209.9M | ||
| Q2 24 | $-4.6M | $56.9M | ||
| Q1 24 | $-6.4M | $74.4M |
自由现金流率APYXTFX
| Q4 25 | -14.6% | 23.1% | ||
| Q3 25 | -31.5% | 8.5% | ||
| Q2 25 | -13.2% | -3.4% | ||
| Q1 25 | -8.0% | 6.2% | ||
| Q4 24 | -22.4% | 21.4% | ||
| Q3 24 | -40.0% | 27.5% | ||
| Q2 24 | -38.0% | 7.6% | ||
| Q1 24 | -62.2% | 10.1% |
资本支出强度APYXTFX
| Q4 25 | 1.4% | -0.2% | ||
| Q3 25 | 4.0% | 3.3% | ||
| Q2 25 | 2.3% | 4.4% | ||
| Q1 25 | 0.6% | 4.3% | ||
| Q4 24 | 1.7% | 4.0% | ||
| Q3 24 | 1.3% | 2.8% | ||
| Q2 24 | 2.4% | 4.6% | ||
| Q1 24 | 0.3% | 5.2% |
现金转化率APYXTFX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 0.77× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.08× | ||
| Q2 24 | — | 1.15× | ||
| Q1 24 | — | 7.38× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
